CLWT vs DHR vs TMO vs CODA vs A

For growth investors, Coda Octopus Group, Inc.

(CODA) is the stronger pick with 30. 7% revenue growth year-over-year, versus -14. 3% for Euro Tech Holdings Company Limited (CLWT). Euro Tech Holdings Company Limited (CLWT) offers the better valuation at 13. 2x trailing P/E, making it the more compelling value choice. Analysts rate Danaher Corporation (DHR) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Euro Tech Holdings Company Limited (CLWT) is the cheapest at 13.

2x versus Danaher Corporation at 34. 9x. On forward P/E, Thermo Fisher Scientific Inc. is actually cheaper at 19. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Agilent Technologies, Inc. wins at 1. 35x versus Danaher Corporation's 34. 35x — a reasonable growth-adjusted valuation.

Over the past 5 years, Coda Octopus Group, Inc.

(CODA) delivered a total return of +49. 7%, compared to -28. 1% for Euro Tech Holdings Company Limited (CLWT). Over 10 years, the gap is even starker: CODA returned +844. 4% versus CLWT's +164. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Euro Tech Holdings Company Limited (CLWT) is the lower-risk stock at 0.

37β versus Agilent Technologies, Inc. 's 1. 23β — meaning A is approximately 229% more volatile than CLWT relative to the S&P 500. On balance sheet safety, Euro Tech Holdings Company Limited (CLWT) carries a lower debt/equity ratio of 1% versus 76% for Thermo Fisher Scientific Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Coda Octopus Group, Inc.

(CODA) is pulling ahead at 30. 7% versus -14. 3% for Euro Tech Holdings Company Limited (CLWT). On earnings-per-share growth, the picture is similar: Coda Octopus Group, Inc. grew EPS 15. 6% year-over-year, compared to -60. 4% for Euro Tech Holdings Company Limited. Over a 3-year CAGR, CODA leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Agilent Technologies, Inc.

(A) is the more profitable company, earning 18. 8% net margin versus 4. 8% for Euro Tech Holdings Company Limited — meaning it keeps 18. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: A leads at 21. 3% versus 2. 5% for CLWT. At the gross margin level — before operating expenses — CODA leads at 66. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Agilent Technologies, Inc. (A) is the more undervalued stock at a PEG of 1. 35x versus Danaher Corporation's 34. 35x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Thermo Fisher Scientific Inc. (TMO) trades at 19. 1x forward P/E versus 22. 5x for Coda Octopus Group, Inc. — 3. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 40. 6% to $247. 00.

In this comparison, CLWT (6.

4% yield), A (0. 8% yield), DHR (0. 7% yield), TMO (0. 4% yield) pay a dividend. CODA does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Euro Tech Holdings Company Limited (CLWT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

37), 6. 4% yield, +164. 8% 10Y return). Both have compounded well over 10 years (CLWT: +164. 8%, TMO: +229. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CLWT (Industrials) and DHR (Healthcare) and TMO (Healthcare) and CODA (Industrials) and A (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CLWT is a small-cap deep-value stock; DHR is a mid-cap quality compounder stock; TMO is a mid-cap quality compounder stock; CODA is a small-cap high-growth stock; A is a mid-cap quality compounder stock. CLWT, DHR, A pay a dividend while TMO, CODA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.